G. Hellner

发表

Potential Use of a Low-Molecular-Weight Heparin to Prevent Restenosis in Patients with Extensive Wall Damage Following Peripheral Angioplasty

W. Kirch, J. Schweizer, A. Müller, 2001, Angiology.

Use of Abciximab and Tirofiban in Patients with Peripheral Arterial Occlusive Disease and Arterial Thrombosis

W. Kirch, J. Schweizer, A. Müller, 2003, Angiology.

Short- and Long-Term Results of Abciximab Versus Aspirin in Conjunction with Thrombolysis for Patients with Peripheral Occlusive Arterial Disease and Arterial Thrombosis

W. Kirch, J. Schweizer, A. Müller, 2000, Angiology.

Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study.

J. Schweizer, E. Altmann, L. Forkmann, 1998, VASA. Zeitschrift fur Gefasskrankheiten.

The case for an individualised management strategy

M. Koch, J. Schweizer, A. Schröder, 2002 .

Short- and long-term results after thrombolytic treatment of deep venous thrombosis.

W. Kirch, R. Koch, J. Schweizer, 2000, Journal of the American College of Cardiology.

Candesartan Treatment for Peripheral Occlusive Arterial Disease after Stent Angioplasty

W. Kirch, J. Schweizer, C. Schindler, 2005, Clinical drug investigation.

Deep Venous Thrombosis Short-and Long-Term Results After Thrombolytic Treatment of Deep Venous Thrombosis

W. Kirch, R. Koch, J. Schweizer, 2016 .

Effect of high dose verapamil on restenosis after peripheral angioplasty.

W. Kirch, J. Schweizer, G. Hellner, 1998, Journal of the American College of Cardiology.